This post has expired! It was posted more than 90 days ago.
<- Back
![]()
![]()
![]()
Describe in what circumstances a multiparametric MRI should be ordered for suspected early prostate cancer
List the biomarker tests that may help define ‘clinically significant’ prostate cancer
Describe the mechanism of action of the new hormonal agents for prostate cancer
List the common side effects of these agents and describe how the side effects can be managed
What’s new in prostate cancer
Speciality Classification
General Practice ( GP ) / Family Medicine
Location
Online
Delivery
Online
On-demand
This webinar focuses on what's new in the diagnosis and management of early prostate cancer, as well as an update in the new drug therapies for advanced prostate cancer.
Learning outcomesThis event attracts 2 CPD points
Title
What’s new in prostate cancer
Speciality Classification
Interest Areas / Topics Covered
Men's health
Provider Type
Non Profit Organisation
